001     280722
005     20240619091200.0
024 7 _ |a 10.1021/acs.jmedchem.5b01215
|2 doi
024 7 _ |a 0022-2623
|2 ISSN
024 7 _ |a 0095-9065
|2 ISSN
024 7 _ |a 1520-4804
|2 ISSN
024 7 _ |a 1943-2992
|2 ISSN
024 7 _ |a WOS:000368564400033
|2 WOS
024 7 _ |a altmetric:4852383
|2 altmetric
024 7 _ |a pmid:26630115
|2 pmid
037 _ _ |a FZJ-2016-00479
041 _ _ |a English
082 _ _ |a 540
100 1 _ |a Vandavasi, Venu Gopal
|0 P:(DE-HGF)0
|b 0
245 _ _ |a Exploring the Mechanism of β-Lactam Ring Protonation in the Class A β-lactamase Acylation Mechanism Using Neutron and X-ray Crystallography
260 _ _ |a Washington, DC
|c 2015
|b ACS
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1453107743_16472
|2 PUB:(DE-HGF)
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|0 0
|2 EndNote
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a article
|2 DRIVER
520 _ _ |a The catalytic mechanism of class A β-lactamases is often debated due in part to the large number of amino acids that interact with bound β-lactam substrates. The role and function of the conserved residue Lys 73 in the catalytic mechanism of class A type β-lactamase enzymes is still not well understood after decades of scientific research. To better elucidate the functions of this vital residue, we used both neutron and high-resolution X-ray diffraction to examine both the structures of the ligand free protein and the acyl–enzyme complex of perdeuterated E166A Toho-1 β-lactamase with the antibiotic cefotaxime. The E166A mutant lacks a critical glutamate residue that has a key role in the deacylation step of the catalytic mechanism, allowing the acyl–enzyme adduct to be captured for study. In our ligand free structures, Lys 73 is present in a single conformation, however in all of our acyl–enzyme structures, Lys 73 is present in two different conformations, in which one conformer is closer to Ser 70 while the other conformer is positioned closer to Ser 130, which supports the existence of a possible pathway by which proton transfer from Lys 73 to Ser 130 can occur. This and further clarifications of the role of Lys 73 in the acylation mechanism may facilitate the design of inhibitors that capitalize on the enzyme’s native machinery.
536 _ _ |0 G:(DE-HGF)POF3-6G15
|f POF III
|x 0
|c POF3-6G15
|a 6G15 - FRM II / MLZ (POF3-6G15)
536 _ _ |a 6G4 - Jülich Centre for Neutron Research (JCNS) (POF3-623)
|0 G:(DE-HGF)POF3-6G4
|c POF3-623
|f POF III
|x 1
588 _ _ |a Dataset connected to CrossRef
650 2 7 |a Biology
|0 V:(DE-MLZ)SciArea-160
|2 V:(DE-HGF)
|x 0
650 1 7 |a Health and Life
|0 V:(DE-MLZ)GC-130-2016
|2 V:(DE-HGF)
|x 1
650 1 7 |a Health and Life
|0 V:(DE-MLZ)GC-130-1
|2 V:(DE-HGF)
|x 0
693 _ _ |a Forschungs-Neutronenquelle Heinz Maier-Leibnitz
|e BIODIFF: Diffractometer for large unit cells
|f NL1
|1 EXP:(DE-MLZ)FRMII-20140101
|0 EXP:(DE-MLZ)BIODIFF-20140101
|5 EXP:(DE-MLZ)BIODIFF-20140101
|6 EXP:(DE-MLZ)NL1-20140101
|x 0
700 1 _ |a Weiss, Kevin L.
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Cooper, Jonathan B.
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Erskine, Peter T.
|0 P:(DE-HGF)0
|b 3
700 1 _ |a Tomanicek, Stephen J.
|0 P:(DE-HGF)0
|b 4
700 1 _ |a Ostermann, Andreas
|0 P:(DE-HGF)0
|b 5
700 1 _ |a Schrader, Tobias E.
|0 P:(DE-Juel1)138266
|b 6
|u fzj
700 1 _ |a Ginell, Stephan L.
|0 P:(DE-HGF)0
|b 7
700 1 _ |a Coates, Leighton
|0 P:(DE-HGF)0
|b 8
|e Corresponding author
773 _ _ |a 10.1021/acs.jmedchem.5b01215
|g p. acs.jmedchem.5b01215
|0 PERI:(DE-600)1491411-6
|p acs.jmedchem.5b01215
|t Journal of medicinal chemistry
|v 59
|y 2015
|x 1520-4804
856 4 _ |u https://juser.fz-juelich.de/record/280722/files/June30th-JACScoates2015TS.pdf
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/280722/files/acs%252Ejmedchem%252E5b01215.pdf
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/280722/files/June30th-JACScoates2015TS.gif?subformat=icon
|x icon
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/280722/files/June30th-JACScoates2015TS.jpg?subformat=icon-1440
|x icon-1440
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/280722/files/June30th-JACScoates2015TS.jpg?subformat=icon-180
|x icon-180
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/280722/files/June30th-JACScoates2015TS.jpg?subformat=icon-640
|x icon-640
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/280722/files/June30th-JACScoates2015TS.pdf?subformat=pdfa
|x pdfa
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/280722/files/acs%252Ejmedchem%252E5b01215.gif?subformat=icon
|x icon
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/280722/files/acs%252Ejmedchem%252E5b01215.jpg?subformat=icon-1440
|x icon-1440
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/280722/files/acs%252Ejmedchem%252E5b01215.jpg?subformat=icon-180
|x icon-180
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/280722/files/acs%252Ejmedchem%252E5b01215.jpg?subformat=icon-640
|x icon-640
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/280722/files/acs%252Ejmedchem%252E5b01215.pdf?subformat=pdfa
|x pdfa
|y Restricted
909 C O |o oai:juser.fz-juelich.de:280722
|p VDB:MLZ
|p VDB
910 1 _ |a Forschungszentrum Jülich GmbH
|0 I:(DE-588b)5008462-8
|k FZJ
|b 6
|6 P:(DE-Juel1)138266
913 1 _ |a DE-HGF
|9 G:(DE-HGF)POF3-6G15
|x 0
|4 G:(DE-HGF)POF
|v FRM II / MLZ
|1 G:(DE-HGF)POF3-6G0
|0 G:(DE-HGF)POF3-6G15
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-600
|b Forschungsbereich Materie
|l Großgeräte: Materie
913 1 _ |a DE-HGF
|b Forschungsbereich Materie
|l Von Materie zu Materialien und Leben
|1 G:(DE-HGF)POF3-620
|0 G:(DE-HGF)POF3-623
|2 G:(DE-HGF)POF3-600
|v Facility topic: Neutrons for Research on Condensed Matter
|9 G:(DE-HGF)POF3-6G4
|x 1
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
914 1 _ |y 2015
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b J MED CHEM : 2014
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b J MED CHEM : 2014
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)JCNS-FRM-II-20110218
|k JCNS (München) ; Jülich Centre for Neutron Science JCNS (München) ; JCNS-FRM-II
|l JCNS-FRM-II
|x 0
920 1 _ |0 I:(DE-Juel1)JCNS-1-20110106
|k Neutronenstreuung ; JCNS-1
|l Neutronenstreuung
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-Juel1)JCNS-FRM-II-20110218
980 _ _ |a I:(DE-Juel1)JCNS-1-20110106
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21